Novartis Pharma Schweiz AG - Tafinlar 50 mg, Hartkapseln | | 62781 | | 01 | | Tafinlar 50 mg | | Hartkapseln | | L01EC02 | | | | 13.01.2014 | | |
| Composition | dabrafenibum 50 mg ut dabrafenibi mesilas, cellulosum microcristallinum, magnesii stearas, silica colloidalis anhydrica, Kapselhülle: hypromellosum, E 171, E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammonii hydroxidum, pro capsula. | Packungsbestandteile | | Capsules | | | | BAG: Active Agent | Dose |
---|
| 50 mg |
| | Inactive agents | | additional_information |
---|
| | | | | | | | | | | | | | color. | | | color. | Hypromellosum | | Kapselhülle | | | Drucktinte | | | | | | | Propylenglycol | | | Silica Colloidalis Anhydrica | | |
| |
| |
|